Redeye comments on the Paxman contract with the US Veterans Association as a sole contractor with th...
Redeye comments on W5’s announcement of a major framework agreement for generators worth up to SEK50...
Redeye presents its preview for Devyser Diagnostics’ Q2 2024 report, due on July 23.
Redeye is encouraged by Nekkar’s acquisition of Globetech which was announced this morning.
Refine Group AB ("Refine", "Koncernen" eller "Bolaget") meddelade den 28 juni år 2024 att dotterbola...
Profitability below expectations Duell’s Q3 net sales came in at EUR 37.
Q2 preview: EBITA growth of 16% y-o-y In Q2, we expect easy growth comps to result in a sequential a...
Luxbright har levererat en första leverans av ett kundspecifikt röntgenrör till Fisica Inc.
Redeye updates its estimates ahead of the Q2 report following today’s announced 5G order.
Redeye comments on EG7’s acquisition of S6 which is the developer and publisher of the online multip...
Redeye offers a preview of Advenica's Q2 results set to be released on July 19th.
Redeye provides an update as we resume our coverage after CLS’ rights issue.
Nettoomsättningen uppgick till 43,7 MSEK (44,4) i det fjärde kvartalet (februari-april) i Purefuns b...
Q2 likely similar to Q1 Q2 seems to have developed in a similar way to Q1, with the trend of longer ...
What to expect in Q2'24 We expect sales of SEK 266m for Q2'24, implying a y-o-y decline of -11%, alo...
